BF.B
48
-5
EW
46
2
CMG
56
8
AON
50
-13
MSFT
58
4
M
25
4
DVA
61
2
WBA
43
2
MRK
41
6
DLTR
54
2
LUV
42
-6
HCA
53
-6
ICE
69
2
LH
42
2
MLM
63
2
JNPR
65
2
WU
30
2
LMT
62
12
NVDA
59
7
PM
89
2
BF.B
48
-5
EW
46
2
CMG
56
8
AON
50
-13
MSFT
58
4
M
25
4
DVA
61
2
WBA
43
2
MRK
41
6
DLTR
54
2
LUV
42
-6
HCA
53
-6
ICE
69
2
LH
42
2
MLM
63
2
JNPR
65
2
WU
30
2
LMT
62
12
NVDA
59
7
PM
89
2
Financhill
Back

CRISPR Therapeutics AG Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34

CRSP
CRISPR Therapeutics AG

Last Price:
$38.28
Seasonality Move:
20.1%

7 Day Trial

ALL ACCESS PASS

$ 7

CRISPR Therapeutics AG Stock Forecast

  • Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 32.6% based on the past 8 years of stock performance.
  • CRISPR Therapeutics AG has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is CRISPR Therapeutics AG Stock Undervalued?
    The current CRISPR Therapeutics AG [CRSP] share price is $38.27. The Score for CRSP is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will CRISPR Therapeutics AG Stock Go Up Next Year?

  • Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 32.6% based on the past 8 years of stock performance.

CRISPR Therapeutics AG Stock Rating

Sell
34
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG overpriced?

  • CRISPR Therapeutics AG has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

CRISPR Therapeutics AG Stock Price History

Is CRSP stock going to rise?

  • The current trend is moderately bullish and CRSP is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crisprtx.com

52-Week Data

52-Week High:
67.88
52-Week Low:
30.04

Prediction Charts

Market Cap:
3.3B
Price in USD:
38.27
Volume:
1.3M
Beta:
2.04

Technical Analysis

SMA50:
40.71
SMA100:
42.02
SMA200:
45.82
52-Wk Change:
-28.77%

Stock Predictions

  • Is CRISPR Therapeutics AG stock public?
    Yes, CRISPR Therapeutics AG is a publicly traded company.
  • What is the CRISPR Therapeutics AG stock quote today?
    The CRISPR Therapeutics AG stock price is 38.27 USD today.
  • How to buy CRISPR Therapeutics AG stock online?
    You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-7 30.88 32.38 34.22 30.04
Apr-8 34.65 31.27 35.38 30.87
Apr-9 30.56 34.89 35.06 30.52
Apr-10 34.01 34.26 34.77 32.90
Apr-11 34.44 39.30 39.30 34.44
Apr-14 40.00 38.81 40.13 37.62
Apr-15 38.42 38.95 39.89 38.27
Apr-16 38.43 37.78 38.50 36.74
Apr-17 37.23 37.77 38.22 37.23
Apr-21 37.06 37.82 39.27 36.66
Apr-22 38.49 39.23 39.85 38.34
Apr-23 40.11 38.54 40.73 38.54
Apr-24 38.73 39.11 39.35 38.25
Apr-25 38.73 38.27 39.05 37.93

CRISPR Therapeutics AG Earnings

CRISPR Therapeutics AG Earnings Report: Per Share CRISPR Therapeutics AG Earnings Q1 Q2 Q3 and Q4 last year and next year.

CRISPR Therapeutics AG Forecast Revenue Growth

CRISPR Therapeutics AG Stock Analysis: Historical quarterly revenues per share for CRISPR Therapeutics AG and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.04 per share, an increase this year of $0.16 per share, and an increase next year of $0.94 per share.

* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.